Logicbio Therapeutics Stock Technical Analysis

LOGCDelisted Stock  USD 2.07  0.00  0.00%   
As of the 25th of April, LogicBio Therapeutics secures the Risk Adjusted Performance of 0.082, mean deviation of 19.25, and Coefficient Of Variation of 865.22. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LogicBio Therapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for eighteen technical drivers for LogicBio Therapeutics, which can be compared to its peers in the industry. Please verify LogicBio Therapeutics treynor ratio, and the relationship between the variance and potential upside to decide if LogicBio Therapeutics is priced some-what accurately, providing market reflects its recent price of 2.07 per share. Please also check out LogicBio Therapeutics sortino ratio, which is currently at 2.13 to check the company can sustain itself at a future point.

LogicBio Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as LogicBio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LogicBio
  
LogicBio Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
LogicBio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of LogicBio Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of LogicBio Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

LogicBio Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

LogicBio Therapeutics Trend Analysis

Use this graph to draw trend lines for LogicBio Therapeutics. You can use it to identify possible trend reversals for LogicBio Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual LogicBio Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

LogicBio Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for LogicBio Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.04  , which means LogicBio Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 64.91, which is the sum of squared deviations for the predicted LogicBio Therapeutics price change compared to its average price change.

About LogicBio Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of LogicBio Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of LogicBio Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on LogicBio Therapeutics price pattern first instead of the macroeconomic environment surrounding LogicBio Therapeutics. By analyzing LogicBio Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of LogicBio Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to LogicBio Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

LogicBio Therapeutics April 25, 2024 Technical Indicators

Most technical analysis of LogicBio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for LogicBio from various momentum indicators to cycle indicators. When you analyze LogicBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the LogicBio Therapeutics information on this page should be used as a complementary analysis to other LogicBio Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in LogicBio Stock

If you are still planning to invest in LogicBio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LogicBio Therapeutics' history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency